Category Specific RSS

Categories: News

SenSen getting sued, executes layoffs but also enjoys record customer cash receipts of over $5 million

Smart city tech company SenSen’s (ASX: SNS) revenue is up, cash receipts have increased and loans are repaid. Oh, and yeah, it is facing a lawsuit and laying off employees to cut costs. 

For most companies, the latter would be big deals; but for SenSen, they are minor inconveniences requiring brief mentions. 

In Q2 FY23, the Company recorded customer cash receipts of $2.6 million, representing a 72% increase on Q2 FY22. In the first half of 2023, it received customer cash receipts of $5.2 million, a 54% increase on H1 FY22. Moreover, it has cash reserves of $3.7 million, versus $3.2 million at the end of September 2022. 

The Company is in a sweet financial position following the receipt of a $2.3 million tax return incorporating the company’s R&D grant. It helped fully repay a loan of $1.5 million from Rocking Horse Capital. To replace this loan, the Company was successful in obtaining an interim facility with Rocking Horse Capital, based on a completed R&D of $1.1 million.

Now, its annual recurring revenue stands at $8 million, with SenSen hoping to approach $10 million by the end of FY23. 

SenSen is an artificial intelligence-based data fusion enterprise that helps customers automate various processes. The Company has created solutions for a range of businesses, including Smart Cities, Casinos, Airports and Retail. It has clients on four continents, with a prominent presence in Australia, New Zealand, Singapore, USA, Canada, India and UAE. 

The numbers will have you believe that all is rosy in SenSen’s world. However, the Company is undertaking an organisational restructure, laying people off to ensure it reaches its revenue target. One part of this involves laying off 26 full-time employees and two roles being reduced to part-time capacities. Given that the Company spends over $2 million on employee costs, these layoffs—along with restricting other controllable expenditures—will allow SenSen to save $2.5 million annually. 

Moreover, the Company is also being taken to court for patent infringement claims. On December 16, 2022, the Company reported that it had been served with Federal Court of Australia proceedings by the solicitors for gaming company Angel Group Co., Ltd and Angel Australasia Pty Ltd. As per the claim, SenSen has infringed two of Angel’s Australian patents. The Company states otherwise.

In 2019, the two companies came together via a $10 million deal, wherein Angel Playing Cards company became the official distributor of SenSen’s SenGAME. According to SenSen, Angel owes the Company distributor fees. SenSen plans on defending these proceedings and even filing a crossclaim against Angel to claim relief for “unjustified threats of patent infringement and invalidity of the Angel patents in the suit”. 

It does not expect this trial to affect its business, given that its gaming arm contributes less than 10% of revenue. However, it could hurt the Company’s reputation. 

A lot hangs in the balance for SenSen. Over the past six months, between August 2022 and January 2023, the Company’s share price has fallen by nearly 50%, reaching $0.049 in January.

Alinda Gupta

Alinda is a Business Reporter for The Sentiment

Recent Posts

Atomo Locks in US$410K Pascal Order as FebriDx Demand Accelerates in the US

Atomo Diagnostics (ASX:AT1) has secured a significant new order for its patented Pascal cassette, with…

1 week ago

June 2025 quarter CPI no roadblock to August RBA rate cut

The June 2025 quarter CPI data released today were cheered by mortgage holders and share…

2 weeks ago

Vection Secures $7.3M Defence Extension as AI Demand Strengthens

AI Gains Ground in Defence Sector As governments increase investment in defence technology, AI-powered tools…

2 weeks ago

Calix Secures $44.9m ARENA Grant to Build Green Iron Plant with ZESTY Technology

Calix Limited (ASX:CXL) has taken a significant leap forward in developing Australia’s low-emissions steel value…

3 weeks ago

Harris Technology boosts retail margins in FY25 through growth of refurbished tech

Online tech retailer Harris Technology (ASX: HT8) has delivered a strong lift in gross product…

3 weeks ago

Lumos Diagnostics Secures US$317M Deal to Distribute FebriDx® in U.S.

In a significant move set to reshape rapid diagnostics in the U.S., ASX-listed Lumos Diagnostics…

4 weeks ago